Replication Data for: Communication about Vaccine Efficacy and COVID-19 Vaccine Choice:  Evidence from a Survey Experiment in the United States
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'While mass vaccination campaigns against COVID-19 have inoculated almost 200 million Americans and billions more worldwide, significant pockets of vaccine hesitancy remain.  Research has firmly established that vaccine efficacy is an important driver of public vaccine acceptance and choice.  However, current vaccines offer widely varying levels of protection against different adverse health outcomes of COVID-19.  This study employs an experiment embedded on a survey of 1,194 US adults in June 2021 to examine how communications about vaccine efficacy affect vaccine choice.  The experiment manipulated how vaccine efficacy was defined across four treatments: (1) protection against symptomatic infection; (2) protection against severe illness; (3) protection against hospitalization/death; (4) efficacy data on all three metrics.  The control ' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["COVID-19","efficacy","public opinion","vaccine"]} <|eot_id|>
 Here is the Description of a dataset. Description:'While mass vaccination campaigns against COVID-19 have inoculated almost 200 million Americans and billions more worldwide, significant pockets of vaccine hesitancy remain.  Research has firmly established that vaccine efficacy is an important driver of public vaccine acceptance and choice.  However, current vaccines offer widely varying levels of protection against different adverse health outcomes of COVID-19.  This study employs an experiment embedded on a survey of 1,194 US adults in June 2021 to examine how communications about vaccine efficacy affect vaccine choice.  The experiment manipulated how vaccine efficacy was defined across four treatments: (1) protection against symptomatic infection; (2) protection against severe illness; (3) protection against hospitalization/death; (4) efficacy data on all three metrics.  The control ' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
While mass vaccination campaigns against COVID-19 have inoculated almost 200 million Americans and billions more worldwide, significant pockets of vaccine hesitancy remain.  Research has firmly established that vaccine efficacy is an important driver of public vaccine acceptance and choice.  However, current vaccines offer widely varying levels of protection against different adverse health outcomes of COVID-19.  This study employs an experiment embedded on a survey of 1,194 US adults in June 2021 to examine how communications about vaccine efficacy affect vaccine choice.  The experiment manipulated how vaccine efficacy was defined across four treatments: (1) protection against symptomatic infection; (2) protection against severe illness; (3) protection against hospitalization/death; (4) efficacy data on all three metrics.  The control 
COVID-19; efficacy; public opinion; vaccine